Wegovy (semaglutide) is a GLP-1 receptor agonist weight loss medication approved by the U.S
34 Tobacco and nicotine
Weinberger DR, Berman KF, Suddath R, Torrey EF (1992)
Patients should seek medical evaluation for severe pain after injury, inability to bear weight, major swelling, deformity, numbness, weakness, fever, signs of infection, worsening abdominal pain, blood in stool, persistent vomiting, chest pain, shortness of breath, or neurological symptoms
Kassardjian CD, Widdifield J, Paterson JM, Kopp A, Nagamuthu C, Barnett C, et al
8 weeks: ~11 vials 12 weeks: ~17 vials 16 weeks: ~22 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 16 weeks (once daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per 10 mg vial for reconstitution